Mohammad Keyvanloo Shahrestanaki
Overview
Explore the profile of Mohammad Keyvanloo Shahrestanaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
33
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keyvanloo Shahrestanaki M, Karami H, Lotfi H, Khorasani M, Babaei Z, Salari Zare M, et al.
Iran J Child Neurol
. 2024 Oct;
18(4):9-21.
PMID: 39478950
Anxiety disorders (ADs) are a group of mental disorders characterized by feelings of tension, fear, and excessive worrying in the face of life experiences. Aberrant signaling of adenosine A2a receptor...
2.
Bagheri M, Aghaabdollahian S, Rezaei M, Gholian Kholerdi A, Raei M, Keyvanloo Shahrestanaki M
Adv Biomed Res
. 2024 Sep;
13:34.
PMID: 39234433
Background: LINC00092 and MCM3AP-AS1 long non-coding RNAs (LncRNAs) play significant roles in the development and pathogenesis of many cancers. However, their expression levels and prognostic values were not evaluated in...
3.
Khosrojerdi M, Lotfi H, Babaei Z, Mirhamidi M, Keyvanloo Shahrestanaki M
Int J Environ Health Res
. 2024 Apr;
34(12):4074-4095.
PMID: 38591760
Perfluoroalkyl substances (PFAS) as a large group of synthetic compounds widely contaminated the environment and lead to health problems. However, the correlation between PFAS exposure, bone health parameters and osteoporosis...
4.
Sisakht M, Keyvanloo Shahrestanaki M, Fallahi J, Razban V
Curr Comput Aided Drug Des
. 2024 Jan;
PMID: 38192133
Background: Virtual screening (VS) is essential for analyzing potential drug candidates in drug discovery. Often, this involves the conversion of large volumes of compound data into specific formats suitable for...
5.
Babaei Z, Keyvanloo Shahrestanaki M, Aghaei M
Pathol Res Pract
. 2023 Jul;
248:154671.
PMID: 37418995
Combating with the cancer, as one of the leading causes of morbidity and mortality worldwide, scientific community extensively evidenced microRNA 1236 (miR-1236) roles in the pathogenesis of malignant tumors. It...
6.
Keyvanloo Shahrestanaki M, Aghaei M
Res Pharm Sci
. 2019 Oct;
14(2):107-114.
PMID: 31620186
Diabetes incidence showed ascending trends in recent years indicating urgent need for new therapeutic agents. Extracellular adenosine signaling showed promising results. However, role of its A3 receptor in pancreatic β-cells...
7.
Keyvanloo Shahrestanaki M, Bagheri M, Ghanadian M, Aghaei M, Jafari S
J Cell Biochem
. 2019 Jun;
120(10):18309-18319.
PMID: 31161672
Natural products are considered recently as one of the source for production of efficient therapeutical agents for breast cancer treatment. In this study, a sesquiterpene lactone, 13-O-acetylsolstitialin A (13ASA), isolated...
8.
Keyvanloo Shahrestanaki M, Panahi Arasi F, Aghaei M
Eur J Pharmacol
. 2019 Feb;
850:88-96.
PMID: 30772395
Signaling through A adenosine receptor specifically prevent pancreatic β-cells (PBCs) loses under diabetogenic conditions. However, signaling mediators of this receptor in PBCs remained unidentified. Thus, we aimed to investigate the...
9.
Keyvanloo Shahrestanaki M, Panahi Arasi F, Aghaei M
J Cell Biochem
. 2018 Nov;
120(5):7759-7770.
PMID: 30417434
Chronic exposure to high glucose induces endoplasmic reticulum (ER) stress in pancreatic beta cells (PBCs). The previous evidence showed that adenosine modulate PBCs viability and insulin secretion. The aim of...
10.
Poupel F, Aghaei M, Movahedian A, Jafari S, Keyvanloo Shahrestanaki M
Int J Prev Med
. 2017 Nov;
8:78.
PMID: 29114376
Background: Dihydroartemisinin (DHA) is a semisynthetic derivative of artemisinin and has antiproliferative effect. However, such effects of DHA have not yet been revealed for bladder cancer cells. Methods: We used...